Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 443269Generated: October 26, 2026

4-((5-(Chloromethyl)-1H-imidazol-1-yl)methyl)benzonitrile hydrochloride → Ethyl 1-[3-(4-cyanobenzyl)-2-methyl-3H-imidazol-4-ylmethyl]-4-(3-nitrobenzyl)piperidine-4-carboxylate

https://huagongshe.com/reaction/443269

Reaction equation

Participants

RoleNameHCIDCharge
Reactant4-((5-(Chloromethyl)-1H-imidazol-1-yl)methyl)benzonitrile hydrochlorideHCID 9795357—
Reactant1-(4-Cyanobenzyl)-5-chloromethyl-2-methylimidazole hydrochloride saltHCID 21193348—
Reactantethyl N-tert-butoxycarbonyl-4-(3-nitrobenzyl)piperidine-4-carboxylateHCID 53931544—
ProductEthyl 1-[3-(4-cyanobenzyl)-2-methyl-3H-imidazol-4-ylmethyl]-4-(3-nitrobenzyl)piperidine-4-carboxylateHCID 21193331—

Reaction Steps

The title compound was prepared using the protocol described in Example 61, Step B-C substituting methyl N-tert-butoxycarbonyl-4-(3-methylbenzyl)piperidine-4-carboxylate with ethyl N-tert-butoxycarbonyl-4-(3-nitrobenzyl)piperidine-4-carboxylate in Step B, and 1-(4-cyano-benzyl)-5-chloromethylimidazole hydrochloride salt with 1-(4-cyano-benzyl)-5-chloromethyl-2-methylimidazole hydrochloride salt (Example 53, Step B) in Step C.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS05891889
Source datasetuspto-grants-1999_04
ORD IDord-99667d348a514220b40532603891398f
Source noteuspto-grants-1999_04